New Chair of Trustees
We are delighted to welcome Kathy Evans as our new Chair of Trustees.
Search
Search results
‘Talking’ Home & Garden Peer Support Group
Tuesday 3 November 2026, 7.00pm - 8.00pm - via Zoom - Please join facilitators Brian & Steve where we invite you to celebrate National Homemaker Day with us by sharing your tips, hints & advice on how we can make our home & garden easier to manage.
‘Talking’ Creative Arts Peer Support Group
Thursday 10 September 2026, 7.00pm - 8.00pm - via Zoom - Please come and join facilitators Steve & Brian for our latest meeting where we are delighted to be joined by our guest speaker David Grigor, Artist, Author and Inclusive Creative Practitioner.
‘Talking’ Books Peer Support Group
Wednesday 12 August 2026, 7.00pm - 8.00pm - via Zoom - Please come and join facilitators Cindy & Jane for our latest meeting where we will be reviewing our current book choice and discussing your suggestions and ideas for our next read.
One-Year Survival of Transplanted Cells Marks Progress in Early Retinal Regeneration Studies
Researchers have recently presented promising clinical data at the International Society for Stem Cell Research demonstrating that transplanted human neural progenitor cells survived for at least one year in participants with Retinitis Pigmentosa (RP).
RTx-015: Exploring Optogenetic Gene Therapy for RP and Choroideremia
Ray Therapeutics, a clinical stage biopharmaceutical company, is currently investigating their lead optogenetic therapy candidate, RTx-015, in early stage clinical trials for those with RP and Choroideremia.
RP Awareness Month – Paul’s Story
During RP awareness month, Paul Bacon has shared how his diagnosis has impacted his life and shared messages about how non visually impaired people can support those living with inherited sight loss. To learn more about inherited sight loss please take the time to read Paul's story.
Meet our supporters: William Taylor
Fundraising for Retina UK means a lot to me - both my dad and my nephew have been affected by inherited sight-loss, and I've seen first-hand the incredible work this charity does.
Meet a researcher: Chloe Brotherton
As part of our aim to nurture young scientists, we are very pleased to introduce one of our new PhD students as part of a co-funding agreement with the Macular Society.
Slowing sight loss in stargardts: Ocugen’s gene therapy trial offers promising early results
Ocugen’s gene therapy candidate, OCU410ST, is an experimental treatment designed to slow vision loss in Stargardt disease, an inherited retinal disease (IRD) with no approved therapies currently.